Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
05/09/2025
Nasdaq is considering speeding up the delisting process for companies with market values below $5 million.
Latest
3 m ago
European Commission President Antonio Costa: EU team will travel to Washington for sanctions negotiation.
3 m ago
According to the AI flash news of Every Media, Dongwu Securities released a research report on September 5, giving a buy rating for Yingke Renewable Energy (688087.SH). The main reasons for the rating include: 1) The proportion of finished frames and decorative building materials revenue exceeds 75%, with a 38% increase in decorative building materials revenue in 2025H1; 2) Operating cash flow net amount increased by 17.50% in 2025H1; 3) The gradual release of manufacturing capacity in Southeast Asia, increased expansion in emerging markets, and enhanced operational resilience; 4) The first midterm dividend, improving shareholder returns. (Daily Economic News)
3 m ago
Shen Textile A: Chairman Yin Kefei resigns
4 m ago
China Shipbuilding (00317.HK): Chen Liping resigns as director and general manager.
4 m ago
BioNTech's experimental breast cancer drug has been successful in trials.
See all latest